Isavuconazole is a broad-spectrum triazole antifungal agent used as the active moiety of the prodrug isavuconazonium sulfate to treat invasive aspergillosis and invasive mucormycosis. By inhibiting the… Read more


















































Isavuconazole is a broad-spectrum triazole antifungal agent used as the active moiety of the prodrug isavuconazonium sulfate to treat invasive aspergillosis and invasive mucormycosis. By inhibiting the fungal cytochrome P450-dependent enzyme lanosterol 14-alpha-demethylase, it disrupts ergosterol biosynthesis, compromising fungal cell membrane integrity and function. This category provides essential pharmaceutical reference standards for isavuconazole, including its pharmacopeial and non-pharmacopeial impurities, degradation products, and related synthetic intermediates. Pharmaceutical laboratories utilize these high-quality compounds for critical analytical tasks, including impurity profiling, stability studies, and method validation to ensure regulatory compliance and therapeutic safety. Furthermore, stable isotope labelled compounds such as deuterium-labelled standards are available to support precise quantitative analysis and quality control in complex biological matrices. These materials are vital for accurate characterization and research throughout the drug development and manufacturing lifecycle.